Methotrexate and misoprostol teratogenicity: Further expansion of the clinical manifestations

American Journal of Medical Genetics, Part A

Volumn 155, Issue 7, 2011, Pages 1723-1728

  Kozma, Chahira ^a   Ramasethu, Jayashree ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Arrhinencephaly; Embryopathy; Medical abortion; Methotrexate; Misoprostol; Pulmonary hypoplasia; Teratogen

Indexed keywords

METHOTREXATE; MISOPROSTOL; NITRIC OXIDE; OXYGEN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; AUTOPSY; BRACHYCEPHALY; BRAIN MALFORMATION; CASE REPORT; CLEFT PALATE; CLINODACTYLY; CRYPTORCHISM; DIFFERENTIAL DIAGNOSIS; DIVERGENT STRABISMUS; ECHOGRAPHY; EXOPHTHALMOS; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GROWTH RETARDATION; HUMAN; LUNG HYPOPLASIA; MALE; MEDICAL ABORTION; MICROGNATHIA; MUSCLE HYPOTONIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSISTENT PULMONARY HYPERTENSION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RIB MALFORMATION; ROBERTS SYNDROME; SKULL DEFECT; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ABORTIFACIENT AGENTS; FATAL OUTCOME; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHOTREXATE; MISOPROSTOL; PHENOTYPE; TERATOGENS;

EID: 79959496236     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.34037     Document Type: Article

References (32)

1. Adam MP, Manning MA, Beck AE, Kwan A, Enns GM, Clericuzio C, Hoyme HE. 2003. Methotrexate/misoprostol embryopathy: Report of four cases resulting from failed medical abortion. Am J Med Genet Part A 123A: 72-78.
2. Allen R, O'Brien BM. 2009. Uses of misoprostol in obstetrics and gynecology. Rev Obst Gynecol 2: 159-168.
3. Bartz D, Goldberg A. 2009. Medication F abortion. Clin Obst Gynecol 52: 140-150.
4. Bawle EV, Conrad JV, Weiss L. 1998. Adult and two children with fetal methotrexate syndrome. Teratology 57: 51-55.
5. Blanchard K, Winikoff B, Ellertson C. 1999. Misoprostol used alone for the termination of early pregnancy: A review of the evidence. Contraception 59: 209-217.
6. Bos-Thompson MA, Hillaire-Buys D, Roux C, Faillies JL, Amram D. 2008. Moebius syndrome in a neonate after mifepristone and misoprostol elective abortion failure. Ann Pharmacother 42: 888-892.
7. Coelho KE, Sarmento MF, Veiga CM, Speck-Martins CE, Safatle HP, Castro CV, Niikawa N. 2000. Misoprostol embryotoxicity: Clinical evaluation of fifteen patients with arthrogryposis. Am J Med Genet 95: 297-301.
8. Creinin MD, Potter C, Holovanisin M, Janczukiewicz L, Pymar HC, Schwartz JL, Meyn L. 2003. Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion. Am J Obstet Gynecol 188: 664-669.
9. Darab DJ, Minkoff R, Sciote J, Sulik KK. 1987. Pathogenesis of median facial clefts in mice treated with methotrexate. Teratology 36: 77-86.
10. Del Campo M, Kosaki K, Bennett FC, Jones KL. 1999. Developmental delay in fetal aminopterin/methotrexate syndrome. Teratology 60: 10-12.
11. DeLoia JA, Stewart- Akers AM, Creinin MD. 1998. Effect of methotrexate on trophoblast proliferation and local immune responses. Hum Reprod 13: 1063-1069.
12. DeSesso JM. 1981. Comparative ultrastructural alterations in rabbit limb-buds after a teratogenic dose of either hydroxyurea or methotrexate. Teratology 23: 197-215.
13. DeSesso JM, Jordan RL. 1977. Drug-induced limb dysplasias in fetal rabbits. Teratology 15: 199-211.
14. Feldkamp M, Carey JC. 1993. Clinical teratology counseling and consultation report: Low dose methotrexate exposure in the early weeks of pregnancy. Teratology 47: 533-539.
15. Goffman D, Cole DS, Bobby P, Garry DJ. 2006. Failed methotrexate termination of pregnancy: A case report. J Perinatol 26: 645-647.
16. Gonzalez CH, Marques-Dias MJ, Kim CA, Sugayama SM, Da Paz JA, Huson SM, Holmes LB. 1998. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 351: 1624-1627.
17. Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. 2004. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2: CD002855.
18. Lewden B, Vial T, Elefant E, Nelva A, Carlier P, Sescotes J. French Network of Regional Pharmacovigilance Centers. 2004. Low dose methotrexate in the first trimester of pregnancy: Results of a French collaborative study. J Rheumatol 31: 2360-2365.
19. Lloyd MA, Carr M, McElhatton P, Hall GM, Hughes RA. 1999. The effects of methotrexate on pregnancy, fertility, and lactation. Q J Med 92: 551-563.
20. Natekar PE. 2007. Methotrexate induced gross malformations in chick embryos. J Hum Ecol 21: 223-226.
21. Olsen IE, Groveman S, Lawson ML, Clark R, Zemel B. 2010. New intrauterine growth curves based on US data. Pediatrics 125: e214-e244.
22. Ostensen M, Hartmann H, Salvesen K. 2004. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 27: 1872-1875.
23. Paumgartten FJR, Magalhaes-de-Souza CA, de-Carvalho RR, Chahoud I. 1995. Embryotoxic effects of misoprostol in the mouse. Brazil J Med Biol Res 28: 355-361.
24. Philip N, Shannon C, Winikoff B. Editors. 2002. Misoprostol and teratogenicity: Reviewing the evidence. Report of a meeting. Accessed at on August 29, 2009.
25. Rubaltelli FF, Mittiga S, Solito P. 1982. Growth and development of children born to mothers treated with cytotoxic drugs during pregnancy. Helv Paediatr Acta 37: 599-601.
26. Schuler L, Pastuszak A, Sanseverinao TV, Orioli IM, Brunoni D, Ashton-Prolla P, Silva Da Costa F, Giugliani R, Couto AM, Brandao SB, Koren G. 1999. Pregnancy outcome after exposure to misoprostol in Brazil: A prospective, controlled Study. Reprod Toxicol 13: 147-151.
27. Seidahmed MZ, Shaheed MM, Abulbasit OB, Al Dohami H, Babiker M, Abdullah MA, Abomelha AM. 2006. A case of methotrexate embryopathy with holoprosencephaly, expanding the phenotype. Birth Defects Res A Clin Mol Teratol 76: 138-142.
28. Sulik KK, Cook CS, Webster WS. 1988. Teratogens and craniofacial malformations: Relationships to cell death. Development 103: 213-231.
29. Vargas FR, Schuler-Faccini L, Brunoni D, Kim C, Meloni VF, Sugayama SM, Albano L, Llerena JC Jr, Almeida JC, Duarte A, Cavalcanti DP, Goloni-Bertollo E, Conte A, Koren G, Addis A. 2000. Prenatal exposure to misoprostol and vascular disruption defects: A case-control study. Am J Med Genet 95: 302-306.
30. Wheeler M, O'Meara P, Stanford M. 2002. Fetal methotrexate and misoprostol exposure: The past revisited. Teratology 66: 73-76.
31. Yedlinsky NT, Morgan FC, Whitecar PW. 2005. Anomalies associated with failed methotrexate and misoprostol termination. Obstet Gynecol 105: 1203-1205.
32. Yip SK, Tse AO, Haines CJ, Chung TK. 2000. Misoprostol's effect on uterine arterial blood flow and fetal heart rate in early pregnancy. Obstet Gynecol 95: 232-235.